North America Pharmaceutical Dissolution Testing Services Market to Grow with a CAGR of 7.62% through 2029

Growing demand for personalized medicine is expected to drive the North America Pharmaceutical Dissolution Testing Services Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “North America Pharmaceutical Dissolution Testing Services Market – By Country, Competition, Forecast & Opportunities, 2019-2029F”, the North America Pharmaceutical Dissolution Testing Services Market stood at USD 2.16 billion in 2023 and is anticipated to grow with a CAGR of 7.62% through 2029. Bioequivalence studies have become paramount in the development and approval of generic drugs. To demonstrate the equivalence of generic formulations to their branded counterparts, pharmaceutical companies rely on dissolution testing services. These studies are essential for demonstrating that a generic drug releases its active ingredient at a rate similar to that of the reference product. With the increasing demand for cost-effective generic alternatives, the significance of bioequivalence studies has intensified. This, in turn, has driven the demand for dissolution testing services, as they are integral to the successful conduct of these studies and the subsequent market entry of generic drugs. Pharmaceutical companies are increasingly outsourcing various aspects of their research and development processes, including dissolution testing. Outsourcing provides several advantages, such as cost efficiency, access to specialized expertise, and flexibility in resource allocation. Contract research organizations (CROs) and specialized laboratories offering dissolution testing services have emerged as key players in this ecosystem. Pharmaceutical companies can leverage the infrastructure and capabilities of these service providers to streamline their testing processes and focus on core competencies. The outsourcing trend is contributing significantly to the grAowth of the North America Pharmaceutical Dissolution Testing Services Market.

Technological advancements and the integration of automation in dissolution testing have enhanced the efficiency, accuracy, and throughput of testing processes. Automated dissolution testing systems offer precise control over testing parameters, reducing variability and ensuring reproducibility of results. Additionally, these advancements enable real-time monitoring and data collection, facilitating quicker decision-making in drug development. The adoption of sophisticated analytical techniques, such as high-performance liquid chromatography (HPLC) and spectroscopy, further contributes to the accuracy and reliability of dissolution testing services.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Pharmaceutical Dissolution Testing Services Market”

The North America Pharmaceutical Dissolution Testing Services Market is segmented into Services Method, Dissolution Apparatus, Dosage form, Country, and Company. 

Based on the Dissolution Apparatus, the Paddle apparatus segment emerged as the dominant player in the North America market for Pharmaceutical Dissolution Testing Services in 2023. The Paddle apparatus is versatile and suitable for a broad range of drug formulations, particularly for solid oral dosage forms such as tablets and capsules. Its design allows for consistent and reproducible testing across different formulations, making it a preferred choice for routine quality control and comparative studies. The Paddle apparatus offers a standardized method for testing drug dissolution. Its design, which involves a paddle that moves up and down in the dissolution medium, provides a consistent hydrodynamic environment. This standardization is crucial for ensuring that dissolution testing results are reliable, reproducible, and comparable across different laboratories and testing conditions. The Paddle apparatus is relatively straightforward to use, making it a practical choice for routine dissolution testing. Its simplicity contributes to the ease of method development, validation, and routine testing procedures, thereby facilitating the workflow in pharmaceutical laboratories. 

Based on region, Canada is showing significant growth for pharmaceutical dissolution testing services, it play a crucial role in ensuring the quality, efficacy, and safety of pharmaceutical products, particularly oral dosage forms like tablets and capsules. These services are essential for evaluating how a drug dissolves in a controlled environment, which can directly impact its bioavailability and therapeutic effectiveness. The Canadian pharmaceutical industry is subject to rigorous regulatory standards set by Health Canada, which oversees the approval and monitoring of drugs. Dissolution testing, as part of the overall drug development and quality control process, helps manufacturers comply with these regulations by ensuring that drugs meet the necessary criteria for consistent and predictable performance in the human body. Furthermore, Canada’s strong pharmaceutical research and development sector, supported by partnerships between academic institutions, pharmaceutical companies, and contract research organizations (CROs), has led to an increased focus on dissolution testing. This helps to enhance the development of new drug formulations and improve existing ones, ensuring optimal performance.

Major companies operating in North America Pharmaceutical Dissolution Testing Services Market are:

• Intertek Group Plc
• Avivia BV
• Almac Group
• Agilent Technologies, Inc.
• Catalent, Inc.
• Thermofisher Scientific Inc
• Charles River Laboratories
• Cambrex Corporation
• Boston Analytical Sciences
• Pace Analytical Life Sciences

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The North America Pharmaceutical Dissolution Testing Services market is anticipated to experience significant growth in the coming years. The North America Pharmaceutical Dissolution Testing Services Market is poised for substantial growth in the coming years. Anticipated to ride on the back of a thriving pharmaceutical industry and increasing demand for generic drugs, dissolution testing services are becoming indispensable for ensuring drug quality and compliance with stringent regulatory standards. The surge in research and development activities, coupled with a focus on innovative drug formulations, is fueling the need for comprehensive dissolution testing. Additionally, the integration of advanced technologies, automation, and analytical techniques is set to enhance the precision and efficiency of testing processes” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“North America Pharmaceutical Dissolution Testing Services Market Segmented By Services Method (In vitro, In vivo), By Dissolution Apparatus (Basket, Paddle, Others), By Dosage Form (Capsule, Tablets, Others) By Country, Competition, Forecast & Opportunities, 2019-2029F”, has evaluated the future growth potential of North America Pharmaceutical Dissolution Testing Services Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in North America Pharmaceutical Dissolution Testing Services Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com